GL1X · GenesisL1 explorer

MolNFT v1 · #11412 · protein

Vipoxin complex

1JLT · Phospholipase A2 inhibitor: “Vipoxin complex”. X-ray diffraction, 3 pockets (best druggability 0.84). MolNFT v1 #11412 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1JLT
Type
protein
Length
244 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phospholipase A2 inhibitor; Phospholipase A2
EC
3.1.1.4
UniProt
P04084, P14420
Pockets
3 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhospholipase A2 inhibitorprotein12249% helix, 8% strandP04084
BPhospholipase A2 (EC 3.1.1.4)protein12248% helix, 11% strandP14420

Ligands and binding sites

  • MRD · (4R)-2-methylpentane-2,4-diol · additive · chains A, B
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13220.840.9444MRD, MPD
2940.410.7715empty
3660.320.7620empty

Interfaces

1 interface between chains.

  • A–B · 1482 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 disulfide (disulfide).

Compared structures

  • 1JLT · Vipoxin Complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P04084 · AlphaFold monomer V2.0 prediction for acidic phospholipase A2 homolog vipoxin a chain… · a predicted model of the same protein · chain A against A, TM-score 0.99
  • P14420 · AlphaFold monomer V2.0 prediction for basic phospholipase A2 vipoxin B chain (P14420) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.